Introduction: Planar bone scan (PBS) is a standard modality for detecting skeletal metastasis. Although PBS is very sensitive, it lacks specificity, especially when a solitary or few atypical osseous lesions depicted. The addition of SPECT/CT can greatly enhance diagnostic accuracy and help reclassify non-conclusive findings on PBS. In this work, we evaluated the added value of SPECT/CT in characterization of equivocal osseous lesions seen on conventional PBS in breast cancer patients. Materials and Methods: This prospective study recruited patients known to have breast cancer referred for conventional planar bone scanning (PBS).Immediately after PBS was acquired, planar images were reviewed. If two nuclear medicine physicians agreed on the non-conclusive nature of the lesion(s), a targeted SPECT/CT was acquired in the same day, to cover the suspected area. Diagnostic performance indices from both modalities (PBS&SPECT/CT) were compared against the reference standard (clinical/imaging follow-up for at least 6-12 months).
Bone metastases may occur with all malignancies but are most common in carcinomas of the breast (1) .The axial skeleton is involved more than the appendicular skeleton, mostly due to the presence of red bone marrow in the former (2) .Detection of bone metastases in cancer patients is essential for accurate diagnosis and proper patient management (3) .Bone scintigraphy is widely used to exclude or confirm bone metastases, despite its limited specificity in many cases (4) .Degenerative changes frequently result in false positive scintigraphic findings that necessitate additional radiological imaging, mainly plain radiographic images (5) . However, the correlation between projection X-ray or even tomographic CT images and scintigraphic images remains challenging, and in many cases exact anatomical localization cannot be confidently assessed (6) . SPECT-CT system combines the functional benefit of SPECT with anatomical information of CT in a single setting allowing optimum co-registration of both image sets and could be well-utilized for accurately evaluating suspected bone metastasis (7) . Some studies have shown that the number of unclear lesions detected in whole-body planar scintigraphy and SPECT can be significantly decreased using SPECT/CT (8, 9) . Also, SPECT/CT has been shown to increase the accuracy of 
RESULTS:
Patients' demographic data: Figure 1and 2) . 
DISCUSSION:
A major disadvantage of planar bone scintigraphy is its low specificity due to tracer accumulation in benign bone lesions 
CONCLUSIONS:
Our study showed significantly higher inter-reader agreement and diagnostic performance for SPECT/CT compared to PBS readings in patients with breast cancer. Addition of SPECT/CT could significantly impact management with potential for improved outcomes. Further work is needed to identify the sub-groups which could benefit the most from this powerful imaging modality.
